- Home
- LITB vs ANEB Comparison
LITB vs ANEB Comparison
Compare LITB & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- ANEB
- Stock Information
- Founded
- LITB 2007
- ANEB 2020
- Country
- LITB Singapore
- ANEB United States
- Employees
- LITB N/A
- ANEB N/A
- Industry
- LITB Catalog/Specialty Distribution
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- LITB Consumer Discretionary
- ANEB Health Care
- Exchange
- LITB Nasdaq
- ANEB Nasdaq
- Market Cap
- LITB N/A
- ANEB 36.7M
- IPO Year
- LITB N/A
- ANEB 2021
- Fundamental
- Price
- LITB $1.02
- ANEB $1.64
- Analyst Decision
- LITB
- ANEB Buy
- Analyst Count
- LITB 0
- ANEB 1
- Target Price
- LITB N/A
- ANEB $8.00
- AVG Volume (30 Days)
- LITB 21.3K
- ANEB 24.3K
- Earning Date
- LITB 03-24-2025
- ANEB 02-14-2025
- Dividend Yield
- LITB N/A
- ANEB N/A
- EPS Growth
- LITB N/A
- ANEB N/A
- EPS
- LITB N/A
- ANEB N/A
- Revenue
- LITB $333,093,000.00
- ANEB N/A
- Revenue This Year
- LITB N/A
- ANEB N/A
- Revenue Next Year
- LITB N/A
- ANEB N/A
- P/E Ratio
- LITB N/A
- ANEB N/A
- Revenue Growth
- LITB N/A
- ANEB N/A
- 52 Week Low
- LITB $0.91
- ANEB $0.80
- 52 Week High
- LITB $6.00
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- LITB 37.97
- ANEB 56.08
- Support Level
- LITB $0.92
- ANEB $0.91
- Resistance Level
- LITB $1.05
- ANEB $1.20
- Average True Range (ATR)
- LITB 0.05
- ANEB 0.17
- MACD
- LITB 0.01
- ANEB 0.01
- Stochastic Oscillator
- LITB 38.46
- ANEB 60.86
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.